DNA topoisomerase IIβ: A player in regulation of gene expression and cell differentiation

被引:14
|
作者
Vavrova, Anna [1 ]
Simunek, Tomas [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove 50005, Czech Republic
关键词
Topoisomerase II beta; Topoisomerase II inhibitors; Gene expression; Cell cycle; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; LUNG-CANCER; ALPHA; CHEMOTHERAPY; NEURONS; REPAIR; XK469; FORMS;
D O I
10.1016/j.biocel.2012.03.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA topoisomerases II regulate conformational changes in DNA topology. They act on double-stranded DNA, catalyzing its relaxation, decatenation and unknotting. Vertebrate cells express two isoforms of topoisomerase II, which are similar in structure, but different in function and regulation. Whereas the alpha isoform is indispensable for proper cell replication, the functions of the beta isoform as well as reasons for its evolution in vertebrates were long unclear. Unlike topoisomerase II alpha, the beta isoform is predominantly expressed in quiescent cells and has been implicated mainly in the process of gene transcription. Recently, new discoveries point on the role of the topoisomerase II beta in regulation of cellular differentiation and tissue development. Furthermore, contemporary discoveries are raising possibilities for novel therapeutic approaches involving selective targeting of either topoisomerase II isoform in potentiating antitumor and/or reducing adverse effects of topoisomerase II poisons. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:834 / 837
页数:4
相关论文
共 50 条
  • [1] Cell cycle-dependent regulation of the mouse DNA topoisomerase II alpha gene promoter
    Adachi, N
    Kobayashi, M
    Koyama, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (01) : 105 - 109
  • [2] Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIα expression
    Salmena, L
    Lam, V
    McPherson, JP
    Goldenberg, GJ
    BIOCHEMICAL PHARMACOLOGY, 2001, 61 (07) : 795 - 802
  • [3] p53 modulation of DNA topoisomerase IIα gene expression
    Joshi, AA
    Wang, QJ
    Suttle, DP
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2000, 33 (02) : 209 - 216
  • [4] Involvement of DNA topoisomerase IIβ in neuronal differentiation
    Tsutsui, K
    Tsutsui, K
    Sano, K
    Kikuchi, A
    Tokunaga, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) : 5769 - 5778
  • [5] p53 modulation of DNA topoisomerase IIα gene expression
    Ashish A. Joshi
    Qingjian Wang
    D. Parker Stuttle
    Cell Biochemistry and Biophysics, 2000, 33 : 209 - 216
  • [6] Expression of DNA topoisomerase IIα in oligodendroglioma
    Bredel, M
    Gatterbauer, B
    Birner, P
    Haberler, C
    Ströbel, T
    Budka, H
    Rössler, K
    Hainfellner, JA
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1301 - 1304
  • [7] DNA topoisomerase II expression in osteosarcoma
    Balis, U
    Rohr, R
    Adams, R
    Scott, S
    Holden, J
    Pappin, A
    LABORATORY INVESTIGATION, 1996, 74 (01) : 4 - 4
  • [8] Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase IIα, DNA topoisomerase IIβ, and nucleolin with BCR 2 of the ETO gene
    Rubtsov, M. A.
    Razin, S. V.
    Iarovaia, O. V.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2008, 423 (01) : 334 - 336
  • [9] Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase IIα, DNA topoisomerase IIβ, and nucleolin with BCR 2 of the ETO gene
    M. A. Rubtsov
    S. V. Razin
    O. V. Iarovaia
    Doklady Biochemistry and Biophysics, 2008, 423 : 334 - 336
  • [10] DNA topoisomerase I and II expression in drug resistantgerm cell tumours
    D M Berney
    J Shamash
    J Gaffney
    S Jordan
    R T D Oliver
    British Journal of Cancer, 2002, 87 : 624 - 629